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Chapter 1 
 
Introduction 
 
 
 
1.1 Physiology of blood pressure 
 
The cardiac events that occur from the beginning of one heartbeat to the 
next one are called as cardiac cycle. It consists of systole, a phase in which heart 
contracts to eject the blood. The systole is followed by a phase called as diastole 
during which the heart tends to relax and fills itself up (Guyton and Hall 2006). 
  
The circulatory system is categorised into „systemic circulation‟ which is 
otherwise called as peripheral or greater circulation, it supplies to all the tissues of 
the body except the lungs, which are supplied by the pulmonary circulation. 
Arteries are the vessels that carry the blood away from the heart under high 
pressure and therefore arterial walls are stronger, where the blood flow will be 
rapid (Guyton and Hall 2006).  
 
Blood pressure - definition 
Blood pressure “means the force exerted by blood against any unit area of 
the vessel wall” (Guyton & Hall 2006, p. 166), it is generally measured in 
millimetres of mercury (mmHg) for example a 100 mmHg of blood pressure 
means, the force exerted by this blood would be sufficient to push a column of 
mercury up to a level of 100 mm. As the heart pumps the blood directly into the 
aorta in a pulsatile manner, the arterial pressure in the aorta varies between 120 
mmHg during the systole and 80 mmHg during a diastole. During the systemic 
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circulation, the pressure of blood falls progressively, before the blood enters the 
heart through venae cavae its pressure is 0 mmHg. In general the arterial pressure 
is controlled by either local tissue perfusion control or control of cardiac output 
(Guyton and Hall 2006). 
Each blood vessel, be it an artery or a vein has the capability to distend, but 
as the walls of arteries are stronger and less elastic, they distend less, and the 
veins distend almost 8 times as much as the arteries. The distensibility of the 
vessels serves as an important function, in which it allows the blood to flow 
through the tissues in both cardiac systole and diastole (Guyton and Hall 2006).  
Systolic and diastolic blood pressures 
The blood pressure at the height of each pulse is called as the systolic 
blood pressure (SBP). In a normal young adult its value is usually 120 mmHg. The 
blood pressure at the lowest point of the pulse is called as diastolic blood pressure 
(DBP) and in normal young adults it is about 80 mmHg. The difference between 
SBP and DBP is called as pulse pressure (PP) (Guyton and Hall 2006,).  
Regulation of Blood pressure 
The flow of blood through the system is represented by the blood pressure, 
and hence when the rate of blood flow is regulated, blood pressure will also be 
regulated. The blood flow control to any tissue could happen in two ways,  
a) acute control and b) long term control. Acute control is achieved as a 
quick response to constriction of the arterioles and metarterioles. Long term 
control occurs due to slow changes in the flow over a period of time due to the 
tissue needs (Guyton and Hall 2006).  
The autonomic nervous system (CNS) plays a crucial role in the regulation 
of blood flow and thus helps in the short term regulation the blood pressure. The 
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baroreceptors are extremely quick in buffering blood pressure changes (Hall JE. 
1999). The most important nervous mechanisms by which arterial pressure is 
controlled is the barorecptor reflex, this reflex is elicited by the baroreceptors 
present on the walls of large arteries. In case of sudden increased pressure, the 
baroreceptors are stretched and they transmit the signals to the central nervous 
system, which replies through a „feedback‟ signal through the autonomous 
nervous system leading to a fall in the arterial pressure (Guyton and Hall 2006).  
Although nervous control of arterial pressure is one important mechanism to 
control ischemia due to decreased blood flow, the CNS response to decreased 
arterial pressure can only be observed in pressures that are below 60 mmHg, and 
maximum CNS response can be elicited if the pressure falls to as low as 15-20 
mmHg, during which perfusion to the brain might be minimal and close to being 
lethal. If cerebral ischemia persists due to a low blood pressure, the neuronal cells 
will suffer metabolically and within 3 to 10 minutes they might as well become 
inactive, and when the ischemia still continues at the same rate, the neuronal cells 
might die within 20 to 60 minutes (Guyton and Hall 2006).  
Long term control of blood pressure is maintained using different 
physiological mechanisms like the Renal-Body fluid feedback: The balance 
between the intake and output of fluids in the body determines the extracellular 
fluid volume and the extracellular fluid volume in turn maintains the blood 
pressure. The renin-angiotensin-aldosterone system and the pressure natriuresis 
mechanisms help in regulating the renal excretion of salt and water (Hall JE. 
1999).  
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Humoral regulation of the circulation is an important mechanism to regulate 
blood flow with the help of substances released into the body, either from glands 
or from local tissues. These substances are classified into 
1. Vasoconstrictors – substances that constrict the blood vessels thereby 
increase the blood pressure. Examples: Norepinephrine, epinephrine, 
vasopressin, angiotensin and endothelin. 
2. Vasodilators – substances that dilate the blood vessels, there by 
decrease the blood pressure. Examples: Bradykinin, serotonin, 
histamine and prostaglandins. 
The central nervous system (CNS) also plays a crucial role in the regulation 
of blood flow and thus regulates the blood pressure. The capabilities of the 
nervous system for the control of arterial pressure are rapid and usually short 
term. The most important nervous mechanisms by which arterial pressure is 
controlled is the barorecptor reflex, this reflex is elicited by the baroreceptors 
present on the walls of large arteries. In case of sudden increased pressure, the 
baroreceptors are stretched and they transmit the signals to the central nervous 
system, which replies through a „feedback‟ signal through the autonomous 
nervous system leading to a fall in the arterial pressure (Guyton and Hall 2006).  
 
1.2 Blood pressure and age  
 
Changes in the cardiovascular function with aging was studied from as 
early as 1809 and various theories have been put forward to explain the 
physiological responses of cardiovascular system with aging (Nichols et al. 1985). 
Increase in the systolic and diastolic blood pressure with age has been 
consistently demonstrated by the results obtained from the well-known 
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Framingham Heart Study and other studies (Rodriguez et al. 1994, Kannel 2000, 
Vasan et al. 2001). The age-related rise of blood pressure has primarily been 
studied and discussed with respect to hypertension and risk for cardiovascular 
diseases (CVD). In a report by Franklin and Weber (1994) the „vascular overload‟ 
concept to assess the hypertensive cardiovascular risk was discussed. They 
argued that hypertensive cardiovascular risk is related to three circulatory 
abnormalities, increased arteriolar resistance, increased large artery stiffness, and 
early reflection of pulse waves. These three mechanisms together were referred 
as „vascular overload‟. Increased arteriolar resistance is associated with increased 
systolic, diastolic and mean arterial pressures, even in the younger subjects. 
According to Franklin and Weber (1994) with advancing age a rise in the arterial 
stiffness occurs. Increased large artery stiffness is associated with increased 
systolic pressure and also a simultaneous decrease in the diastolic pressure. An 
inelastic or stiff aorta due to aging leads to a diminished reservoir effect at the end 
of the cardiac systole, thereby it contributes to diminished diastolic pressure. 
Young to middle aged hypertensive subjects have a combination of increased 
arteriolar resistance and increased arterial stiffness which contributes to more rise 
in systolic pressure compared to diastole with age. As the age advances there is a 
large rise in the arterial stiffness and  a varied arteriolar resistance, this contributes 
to the isolated systolic or systolic and diastolic hypertension. Also aging and 
hypertension lead to increase pulse wave velocity which in turn leads to early 
pulse wave reflection. This increased arterial stiffness combined with early wave 
reflection result in an increased systolic blood pressure and a decrease in diastolic 
blood pressure, especially in the elderly subjects (Franklin and Weber 1994).  
Chapter 1. Introduction 
 11 
Whelton (1994) found in most surveys, that SBP tends to rise progressively 
throughout childhood, adolescence and adulthood to reach an average value of 
140 mmHg. Although the DBP also rises with age, the rate is not as steep as for 
the SBP. This leads to widening of pulse pressure and more common isolated 
systolic pressure (Whelton 1994). 
 
1.3 Impact of systolic and diastolic blood pressure on CVD 
 
With regard to the prognostic and therapeutic importance of the SBP and 
DBP for CVD a debate over many centuries has been carried out. For example, 
researchers in the eighteenth and the early nineteenth centuries associated the 
„increased arterial pulse tension‟ with hypertensive cardiac and renal sequelae like 
„dropsy‟ and „nephritis‟. In 1874 Fred Mahomed noticed that in subjects with 
albuminuria, high tension in the arterial system coexisted. In the 10th edition of 
Osler‟s classic medical textbook in 1925, normal BP was considered to be 120-
130 mmHg and 130-150 mmHg if the age is over 50 years. In 1927 Cecil‟s classic 
American textbook of medicine stated that systolic pressures of over 250 mmHg 
are quite common and emphasised the importance of diastolic pressure increases 
for the diagnostic as well as prognostic purposes. The same text book in the sixth 
edition in 1943 emphasised on the importance of mean arterial pressure along 
with the diastolic pressure (Rutan et al. 1989).  
Historically, elevated systolic blood pressure was always considered to be 
an inevitable outcome that occurs due to arterial stiffening especially in the elderly. 
When it comes to hypertension, its severity was defined previously with the level of 
diastolic blood pressure until the Framingham Heart study that started in 1948. 
The results of Framingham study repeatedly showed that systolic blood pressure 
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was a better marker for cardiovascular disease than diastolic blood pressure 
especially middle and older age subjects (Kannel 1999). 
Prospective studies like the Chicago stroke study (Shekelle et al. 1974), 
and a study by Rabkin and coworkers. (1978) also showed that a stronger 
association of SBP than DBP was found for the risk of stroke (Shekelle et al. 1974, 
Rabkin et al. 1978). Studies like the Western Collaborative Group Study and a 
Canadian study showed that SBP was found to be a stronger predictor of CHD 
than mean arterial pressure (MAP) and DBP especially in the subjects who were 
under 50 years of age (Rosenman et al. 1976, Rabkin et al. 1978). Other 
prospective studies like the Honolulu Heart Program and the Whitehall Study 
showed that SBP was more strongly related to the CHD mortality than DBP (Yano 
et al. 1983, Lichtenstein et al. 1985). A meta-analysis by Staessen et al. (2000) 
found that a 10 mmHg rise in systolic hypertension is correlated with a 10% 
increase in all fatal and nonfatal cardiovascular complications (Staessen et al. 
2000). Another meta-analysis by He and Whelton (1999) showed that the 
association between SBP and CHD, stroke and end-stage renal disease was 
continuous, graded and independent. It also showed that the association of SBP 
with these outcomes is stronger than that of DBP (He and Whelton 1999). 
Interestingly a study that was conducted by Franklin et al. (2001), using the 
Framingham data with the subjects free of CHD and aged between 20 and 79 
years showed that, with increasing age, there was a gradual shift from DBP to 
SBP and then to PP as predictors of CHD risk. In patients who were younger than 
50 years of age, DBP was the strongest predictor for CHD. In the age group of 50 
to 59 years all the three BP components (SBP, DBP and PP) were comparable 
predictors of CHD and in subjects aged above 60 years, DBP was negatively 
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related to CHD risk and PP became superior to SBP in CHD risk prediction 
(Franklin et al. 2001).  
Domanski et al. (2002) analysed the data from the Multiple Risk Factor 
Intervention Trial (MRFIT) and compared the relationships of SBP, DBP and PP 
separately and jointly, with cardiovascular disease related mortality in men. They 
reported that CVD risk assessment was improved by considering both SBP and 
DBP not SBP, DBP or PP independently (Domanski et al. 2002).  
Franklin and co-workers (2009) showed from the Framingham data that, 
combining PP with MAP and SBP with DBP produced models that were superior 
to single blood pressure components for predicting CVD. They also concluded 
that, combined SBP + DBP, and combined MAP + PP were equally predictive of 
CVD risk (Franklin et al. 2009) 
Although a great amount of research was carried out on blood pressure and 
CVD risk, uncertainty still exists regarding the relative importance of various 
components of blood pressure in predicting the CVD risk and controversy still 
persists about which blood pressure component plays a superior role in predicting 
CVD.  
 
 
1.4 Blood pressure level and risk for cardiovascular disease 
  
It is undisputedly established that hypertension is associated with CHD and 
CVD. The nature of this relationship is well studied. As early as 1969 Kannel et al. 
from the Framingham Heart Study assessed the relationship between blood 
pressure and clinical manifestations of CHD with respect to age. They concluded 
that risk of manifestations of CHD is related to both antecedent systolic and 
diastolic blood pressure. The risk was also proportional to the level of blood 
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pressure even at non hypertensive blood pressures levels. Elevated SBP even 
after the age of 50 years showed a substantial increase in risk of CHD (Kannel et 
al. 2009).  
The relation between blood pressure and CHD manifestations has been 
consistently proven in studies conducted on both sexes and in people with diverse 
geographic, cultural and ethnic backgrounds (Whelton 1994). It was also well 
proven that high blood pressure is a cardiovascular disease risk factor 
independent of the other risk factors that are associated with CVD (Whelton 1994, 
Kannel et al. 2009). 
Although it is known that the risk of CVD increases with increasing blood 
pressure there has always been a question about the threshold level of blood 
pressure above which it is considered as abnormal for the individual. Thus there 
has been always a need to classify the blood pressure with respect to the level of 
risk so as to enable the physicians to set up therapeutic goals.  
Vasan et al. (2001) investigated from the Framingham cohort study, the 
association between blood pressure categories at baseline and incidence of 
cardiovascular disease in Framingham study participants. They concluded that 
high normal blood pressure (SBP of 130 to 139 mmHg or a DBP of 85 to 89 
mmHg) is also associated with an increased risk of cardiovascular disease. Thus, 
questioning the need to see, if lower high-normal pressure can reduce the risk of 
CVD (Vasan et al. 2001). The Prospective Studies Collaboration, which had done 
a meta-analysis with one million adults using 61 prospective studies, concluded 
that, throughout the middle and old age blood pressure is strongly and directly 
related to vascular mortality and without any evidence of a threshold down to at 
least 115/75 mmHg (Lewington et al. 2002). Port et al. (2000) using the 
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Framingham data challenged the concept that lower blood pressures imply lower 
risk and using a cut off value of 140 mmHg for all adults. They concluded that, 
there is an age-dependent and sex-dependent threshold for hypertension (Port et 
al. 2000).  
However, Kannel et al. (2003) in a review stated that, “there is an 
overwhelming evidence of a continuous, graded influence of SBP on CVD 
morbidity and mortality at all ages in both sexes. An optimal BP for avoiding CVD 
is <140/90 mmHg, and there is no clearly defined critical BP that distinguishes 
normal from abnormal” (Kannel et al. 2003, p. 455).  
Kshirsagar et al. (2006) analysed the data from the Atherosclerosis Risk in 
Communities Study and found that “individuals with prehypertensive levels of 
blood pressure have an increased risk of developing cardiovascular disease 
relative to those with optimal levels” (Kshirsagar et al.2006, p. 133).  
Main reason of this long-lasting and controversial debate might be based on 
the fact that blood pressure is a physiological process and a thus continuous 
entity. Therefore the construct of a strict threshold to distinguish between normal 
and abnormal values does not in all cases reflect real physiological processes.  
 
1.5 Risk of progression to hypertension 
 
As it was known that blood pressure progresses with age, studies have 
been conducted to analyse the progression of normal blood pressure and 
prehypertension into hypertension.  
Leitschuh et al. (1991) analysed the blood pressure data from the 
Framingham study, and concluded that the individuals who have high normal 
blood pressure i.e. a DBP of 85-89 mmHg had a 2-3 fold higher probability of 
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developing hypertension, when compared to the individuals with normal blood 
pressure (DBP <85 mmHg) (Leitschuh et al. 1991). 
Vasan et al. (2001) confirmed from their data that high normal BP and 
normal BP tend to progress to hypertension over a period of 4 years, this was 
predominantly found in older adults (Vasan et al. 2001). 
Jimenez-Corona et al. (2007) followed 1572 non hypertensive subjects 
aged between 35 and 64 at baseline for a median period of 5.8 years and found 
that there was a significant association between BP levels at baseline and 
hypertension incidence even within the normotensive subjects (Jimenez-Corona et 
al. 2007). 
 
1.6   Measurement of Blood pressure  
The gold standard for the measurement of arterial blood pressure is the 
direct intra-arterial measurement using a catheter. However, due to the 
impracticability of this technique for day to day practice and for the majorities of 
studies indirect methods for blood pressure measurements, mainly the 
oscillometric and auscultation technique are used. The methodology for the 
indirect method of blood pressure measurement was first reported in 1896 by 
Riva-Rocci, an Italian physician. He described the physical principles involved in 
the measurement of the arterial pressure using a mercury manometer. In 1905 
Korotkoff for the first time reported about the measurement of blood pressure 
using a stethoscope (Booth J 1977). The indirect ausculatory method determines a 
certain pressure level which is required to collapse the arteries either in the upper 
arm or the leg using a sphygmomanometer. The cuff of the sphygmomanometer is 
wrapped around the arm or the leg and inflated to a pressure level above that of 
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the arterial pressure, which is indicated by the obliteration of the arterial pulse. As 
the pressure in the cuff is released gradually by deflating the cuff, the pressure at 
which the arterial pulse waves produces sounds (Korotkoff sounds) that can be 
heard using a stethoscope is noted this is the systolic blood pressure. As the 
pressure in the artery drops down further the pulse wave sounds disappear, this 
pressure is the diastolic blood pressure (Perloff et al. 1993). 
The size and dimensions of the bladder and cuff of the sphygmomanometer 
are important in determining the correct values of blood pressure. The length and 
width of the bladder and their ratio are important. Acceptable standards of the 
width of the bladder are 40% of the arm circumference, and for the length of the 
bladder are 80% of the arm circumference in adults.  
Automatic devices measure the blood pressure using oscillometric and 
auscultatory techniques. The oscillomteric method detects the blood pressure 
based on the oscillations on the lateral walls of the occluded artery. The 
oscillations begin at the systolic blood pressure and reach the greatest amplitude 
at the mean arterial pressure. The diastolic blood pressure is a derivative of SBP 
and mean arterial pressure (Perloff et al. 1993).  
The auscultatory method does not yield exact results, but gives values 
within 10% of those determined by direct measurement from the arteries (Guyton 
and Hall 2006). The auscultatory technique using Korotkoff sounds gives slightly 
lower systolic and slightly higher diastolic blood pressure values when compared 
to intra-aterial measurements of blood pressure (Jones et al. 2003). The 
oscillometric method is based on detecting the oscillations on the lateral walls of 
an occluded artery as the pressure is deflated in the cuff.  SBP measurement by 
these devices is accurate but the DBP may not be. (Perloff et al. 1993) 
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Although practical, the indirect measurement of blood pressure has its own 
problems of accuracy. According to Jones and co-workers (Jones et al. 2003) the 
indirect measurement has accuracy problems for at least 3 reasons: 
1. Inherent biological variability  
2. The white coat effect  
3. Inaccuracies due to suboptimal technique.  
 
1.7  Secular trends of blood pressure  
 
1.7.1 Global trends  
Blood pressure as risk factor for CVD was always well studied. However the 
lion's share of research considers blood pressure in terms of hypertension, 
assessing prevalence, treatment and control of hypertension in diverse 
populations. 
Studies from different parts of the world examined trends of high blood 
pressure prevalences. Most studies from the U.S. used data from the different 
National Health and Nutrition Examination Surveys (NHANES) to examine the 
trends in the prevalence of hypertension. Burt et al. (1995) described the secular 
trends of the distribution of blood pressure and prevalence of hypertension in the 
US adults, using NHANES data from 1960 to 1991. They concluded that 
“hypertension prevalence in the United States has declined progressively since 
1971 and the distributions of systolic and diastolic pressures have shifted 
downward during the approximately 30-year period between 1960-1962 and 1988-
1991” (Burt et al. 1995, p. 60). Hajjar and Kotchen (2003) also using the NHANES 
data described the trends of hypertension prevalence in the US between 1988 and 
2000. Contrary to the previous findings, they observed that hypertension 
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prevalence has increased in the US between 1988 and 2000 (Hajjar and Kotchen 
2003).  
Hypertension prevalence and secular trends have been extensively studied 
in the European populations, too. Banegas et al. (1998) studied the distribution of 
blood pressure among the Spanish population and found that 50% of Spaniards 
aged between 35 and 64 years were hypertensive and 10% had either isolated 
systolic or isolated diastolic hypertension (Banegas et al. 1998). Asmar et al. 
(2001) assessed the prevalences of high blood pressure by using the data of 
61,108 French subjects and found that more than a third of men and nearly a 
quarter of women had high blood pressure (Asmar et al. 2001).  
 
1.7.2 Trends in Germany 
There are a number of studies determining the blood pressure in the 
German population. All of them examined blood pressure readings as a risk factor 
for CVD, focussing their work on the assessment of the prevalence, treatment and 
control of hypertension in the German population. None of the German studies 
reported the distribution of the blood pressure readings.  
Hense (2000) examined the trends in the prevalence of hypertension in 
KORA, a population based study conducted in Augsburg in southern Germany. He 
concluded that between 1984 and 1994 the prevalence of hypertension in the 
Augsburg population was relatively constant (Hense 2000). Gasse et al. (2001) 
analysed blood pressure data from the same study and concluded that the age 
adjusted prevalence of hypertension between 25 and 64 year old subjects did not 
change significantly, with 39% of men and 25% of women found to be 
hypertensive (Gasse et al. 2001).  
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The German National Health Interview and Examination survey 1998 (BGS) 
reported that hypertension was prevalent in nearly 30% men and 27% women. 
The prevalence of hypertension was higher in eastern Germany when compared 
to the West. When compared to the health surveys conducted in 1991, the 
hypertension prevalence increased in western Germany, where as it decreased in 
the east. Just like the findings from other studies in the world, the blood pressure 
data in the BGS also showed that there is a continuous increase in the SBP with 
age in both sexes (Thamm 1999).  
 
 
 
 
 
 
 
 
  21 
Chapter 2 
Aim and Study Questions 
As blood pressure is a continuously distributed feature, prevalence 
estimates are mostly presented as arithmetic means and dispersion around the 
mean (range, standard deviation). Only a few single estimates are thus necessary 
to obtain an overview of the central location of the data and to achieve good 
predictors of the frequency with which a population will be detected as 
hypertensive.  
Nevertheless, epidemiological information throughout the full range of a 
distribution within populations (i.e. percentiles and subgroups age groups) may 
prove helpful in obtaining a more detailed picture of blood pressure distributions. 
For example, it would be interesting to know whether the full range of the blood 
pressure distribution differs between the age classes, i.e. with greater differences 
in the blood pressure range in older age groups compared to the younger ones. 
Furthermore, it would be interesting to know whether the age-related increase in 
blood pressure occurs in each part of the distribution, i.e. even in the lowest 
percentile. 
As discussed above, even though there were some studies focussing on 
the blood pressure in the populations, only few studies worldwide and none in 
Germany examined the percentile distribution of the blood pressure population-
wide. Even more, as to my knowledge, there is no publication evaluating blood 
pressure readings taking into account age, sex and coexisting cardiovascular risk 
factors.
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Main aim of this thesis was to examine the distribution of blood pressure 
readings in the German population using data from a large cross sectional study 
sample of 35,869 women and men aged 18-99 years. In a first analysis step 
following research questions will be addressed 
Part 1:  
 How are the percentiles of the systolic and diastolic blood pressure 
distributed in the German population?  
 How are the blood pressure percentiles distributed with respect to age-
classes and sex? 
 Do the percentile distributions of the systolic and diastolic blood 
pressure observed in the whole study sample differ in a subpopulation 
without known cardiovascular risk factors? 
Part 2:  
In a second step, the observed age effects on blood pressure readings in 
the cross sectional and patient-based GEMCAS study will be reproduced in an 
independent study sample, the prospective and population-based Heinz Nixdorf 
Recall study to answer following question: 
 Is the magnitude of the age related effects on blood pressure observed 
in the cross-sectional GECMAS study sample, comparable to that of an 
independent study sample of a prospective cohort study? 
To answer the study questions, data from the German Metabolic and 
Cardiovascular Risk Study (GEMCAS) and Heinz Nixdorf Recall study were used. 
GEMCAS offers an excellent data set including a broad age range of 18 to 99 
years and a very large sample size that provides sufficient precision even when 
stratifying the sample into small age groups, sex or presence or absence of CVD 
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risk factors. The Heinz Nixdorf Recall study as a prospective, population-based 
cohort study offers an excellent data base to enable verification of the age effects 
observed in GEMCAS. 
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Chapter 3 
Material and Methods  
3.1 GEMCAS 
3.1.1 Study design and participant recruitment  
GEMCAS is a cross sectional study conducted in October 2005 for two 
weeks at 1,511 randomly selected primary care physicians from all over Germany. 
General practitioners and internists with focus on primary health care were 
selected by a stratified, randomized sampling method to receive a random 
distribution across all German regions. Physicians specialized in cardiology and/or 
diabetes were excluded from the study. 
All the subjects who were aged 18 years and above visiting the selected 
primary care physicians during the days on which the study was conducted, 
irrespective of the reason for their visit were included in the study. The only 
reasons for exclusion were conditions that made it impossible or highly 
problematic for the patient to participate (such as poor German language skills, 
serious disabilities or diseases), acute emergencies, or pregnancies and breast-
feeding within the previous three months.  
Ethical approval was granted from the ethics committee of the University 
Hospital, University Duisburg-Essen, Essen, Germany (Moebus et al. 2006). 
 
3.1.2 Data collection 
 
Data were collected through two types of questionnaires. The medical 
questionnaire was completed by the participating physician or his/ her assistant. It 
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furnished all the details about age, reason for attendance, anthropometric 
measurements, pre-existing clinical conditions, medication intake etc. The patient 
questionnaire had the relevant information about age, medical history, family 
anamnesis, lifestyle related and socio-demographic variables used in the study 
Venous blood samples were collected from all the study subjects and shipped to 
the central laboratory in Berlin (Labor 28, Berlin, Germany) by an assigned courier 
service. The samples were analyzed for blood glucose levels, total cholesterol, 
HDL, LDL, and Triglycerides (Moebus et al. 2006). 
 
3.1.3 Blood pressure measurements 
 
Blood pressure was measured using commonly available equipment in the 
physician‟s practice. The blood pressure devices used (manual, automatic, brand 
name) were reported by the physicians. The readings for blood pressure were 
obtained after a five minute rest with the participant in a sitting position. Accepted 
epidemiological standards for blood pressure measurements such as a double 
measurement with at least two minutes of recovery between measurements (i.e. 
Guidelines for the management of arterial hypertension: The Task Force for the 
Management of Arterial Hypertension of the European Society of Hypertension 
(ESH) and of the European Society of Cardiology (ESC) 2007) were not feasible. 
However, reported measurements here represent physician practices procedures. 
 
3.1.4 Data Quality assurance 
 
The study was planned and conducted according to the German guidelines 
for Good Epidemiology Practices (GEP) (Hoffmann et al. 2005). The participating 
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physicians received no other instructions than the information material that was 
sent to them. A special monitoring system was designed to minimize systematic 
errors. The monitoring was done in two ways, telephonic and random on-site 
visits. Telephone monitoring was done at 50% of the enrolled practices prior to the 
day of survey to make sure that the participating physicians had correct knowledge 
of the operation procedures and also had all the relevant material needed for the 
study in the form of questionnaires, other documents and blood sampling 
materials. Physicians to be included in the monitoring were selected randomly and 
stratified into three groups. The interviewers rated the monitored site based on 
standardized interview. Their performance was rated on a scale ranging from one 
to six, with six being the worst rating. Furthermore, in about 10% of the 
participating medical practices random on-site visits were performed during the 
day of survey. These practices were chosen at random prior to the survey. 
Additionally, a special emphasis was laid on sites that received a poor rating 
during the telephonic monitoring and where ever possible these practices were 
included in the list for the on-site monitoring during the survey day (Moebus et al. 
2006).  
 
3.2 Heinz Nixdorf Recall study  
3.2.1 Study design and aims  
The Heinz Nixdorf Recall (Risk Factors, Evaluation of Coronary Calcium 
and Lifestyle) study, henceforth abbreviated as HNR, is a German population-
based prospective cohort study that started in 2000 in the metropolitan Ruhr 
region including the cities Bochum, Essen and Mülheim/R. Main aims of the HNR 
study are to study the extent of subclinical coronary atherosclerosis to predict the 
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risk of myocardial infarction in the general population and to define appropriate 
methods for identifying high-risk subgroups in the general urban population 
(Schmermund et al. 2002).   
 
3.2.2  Participant recruitment 
A detailed description of the recruitment of the participant was discussed in 
detail by Stang et al. (2005). Briefly, for the baseline examination study 
participants were randomly selected from the mandatory registries of residence 
from the three cities included in the study between December 2000 and August 
2003. About 9,484 subjects were invited to participate in the study. A multimode 
contact approach including an invitational letter, a maximum of two reminder 
letters and phone calls were used for the recruitment of study subjects (Stang et 
al. 2005). As the study was aimed at general population very few exclusion criteria 
were applied to the study: inability or unwillingness to give an informed consent to 
participate in the study, conditions (medical or other) that preclude follow-up for 
five years, severe psychiatric disorders or illegal substance abuse and pregnancy 
(Schmermund et al. 2002). 
Overall 4,814 eligible subjects of both sexes, aging 45-75 years could be 
examined, corresponding to a baseline response of 56%. All participants had 
provided the informed consent for the study and the study was approved by the 
local institutional ethics committees. The study also comprised extended quality 
management procedures and was certified according to DIN ISO 9001:2000.  
The follow up has been conducted for a median of 5 years (mean 5.1 ± 0.3 
years). Participants have been annually contacted by a mailed questionnaire. 
Between May 2006 and July 2008 a second medical examination was conducted 
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in the fifth year of follow up, including 4,157 subjects corresponding to a follow up 
response of 90.2% (Erbel et al. 2010). 
 
3.2.3  Blood pressure measurements 
Blood pressure was recorded using an automated oscillometric blood 
pressure device (AOD) (Omron HEM-705CP; OMRON Corporation, Hoofdorp, the 
Netherlands) The AOD displayed blood pressure to the nearest 1 mmHg. Study 
personnel were certified and regularly trained in measuring blood pressure 
according to the standards of the World Health Organization (WHO) MONICA 
blood pressure recording protocol (Stang et al. 2005). 
Blood pressure was recorded three times for each subject with a three 
minute interval in between the measurements. The blood pressure was recorded 
during a computer assisted personal interview that was automatically interrupted 
for blood pressure recording. This ensured that subjects had a rest for at least five 
minutes before their first blood pressure was measured. The first measurement 
was disregarded as it is typically systematically higher than subsequently serial 
measurements. Mean SBP and DBP were calculated from the second and third 
measurements (Stang et al. 2005).  
 
3.2.4 Risk factor assessment 
Behavioural risk factors like smoking, nutrition and physical activity, medical 
family history concerning ischemic heart disease, intake of any medications, and 
information about socio-demographic variables was obtained using questionnaires 
and computer assisted interviews. Laboratory parameters have been conducted 
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immediately at the central laboratory at the University Hospital of Essen 
(Schmermund et al. 2002).  
 
3.3 Diagnostic conventions 
Following diagnostic conventions have been used in all analyses of this 
thesis. 
 Body mass index (BMI): The subjects were classified as normal with 
a BMI between 18 and 24.99 kg/m2, overweight 25 and 29.99 kg/m2, 
obese 30 kg/m2 or more. 
 Smoking status was defined as never smokers, past smokers (quit of 
smoking and time since quitting), and current smokers (actual 
smoking of either cigarettes or other forms of tobacco).  
 CVD in GEMCAS was defined as a history of cardiovascular disease 
reported by the physician, including myocardial infarction or acute 
coronary syndrome.  
 CAD in HNR was defined by self-reports of previous myocardial 
infarction. 
 Diabetes In GEMCAS was defined when the subject had any one of 
the following: a self-reported history of type 1 or type 2 diabetes or a  
reported history of type1 or type 2 diabetes by a physician, intake of 
insulin or oral anti-diabetic medications. In the HNR subjects it was 
defined when the subjects reported a history of the diagnosis or 
intake of glucose lowering drugs.  
 
 
Chapter 3. Material and Methods 
    30 
3.4 Statistical Analyses  
Of the 35,869 study participants included in GEMCAS, 186 with missing 
data for blood pressure readings were excluded for the present analysis, leaving a 
study sample of 35,683 (mean age 51.7±16.1 years, 61.2% women). 
Means and their standard deviation and percentiles (5th, 25th, median, 75th 
and 95th) of SBP and DBP were computed, each stratified by age-groups and sex.  
In sensitivity analyses the percentile distribution of blood pressure in 
“healthy” subjects were studied by excluding (n=24,399) subjects with the following 
cardiovascular risk factors and diseases: elevated waist circumference (>102 cm 
in men, >88 cm in women), elevated triglycerides (≥1.7 mmol/L (150 mg/dl)), low 
high density lipoprotein(HDL) (<1.08 mmol/L (40 mg/dl) in men, < 1.3 mmol/L (50 
mg/dl) in women), elevated blood glucose (GL, fasting GL ≥ 5.6 mmol/L (100 
mg/dl) or non-fasting GL ≥11.1 mmol/L (200 mg/dl)), antihypertensive treatment, 
presence of diabetes mellitus and history of a CVD.  
The characteristics of the GEMCAS subjects were described according to 
10 year age groups. Means, medians and quartiles were reported wherever 
applicable for continuous variables and frequencies were reported for categorical 
variables.  
The characteristics of the subjects of GEMCAS were also stratified 
according the JNC 7 definition of hypertension (Chobanian et al. 2003) to observe 
the prevalences of risk factors in different blood pressure classes according to 
JNC 7.  
As the GEMCAS samples had a very wide age range and to allow for an 
age independent comparison of the study characteristics, a direct age 
standardisation according to the 2004 standard German population (Statistisches 
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Jahrbuch für die Bundesrepublik 2006) has been computed for all variables. For 
this purpose, in a first step the GEMCAS sample was stratified into 5 year age 
classes (18-30, 31-45, 46-60, 60-75 and >76 years). For all variables means 
respective frequencies were computed according to these 5 year age-groups. In a 
second step the age specific rates were (1) multiplied with the proportion of people 
in the respective age groups in the 2004 standard German population to compute 
the expected age specific rates in GEMCAS and (2) summed up to get the directly 
standardized rates. Additionally, 95% confidence intervals (95% CI) for the 
standardized rates were computed by calculating the variance of the standardized 
rate/mean and subsequently using the 97.5% quantile of a standard normal 
distribution to determine the lower and upper confidence bound. 
The characteristics of the GEMCAS study sample were compared to the 
characteristics of the Heinz Nixdorf Recall study population. To make both the 
studies comparable with respect to age, this analysis included only the GEMCAS 
subjects who were aged between 45-75 years.  
  Age and sex specific frequency distribution curves were used to present the 
blood pressure data for the GEMCAS subjects.  
The age effects on blood pressure observed in the cross sectional 
GEMCAS sample (restricted to the age group 45 to 75 years) were validated with 
the data of the prospective study of HNR by applying the observed age-effect in 
GEMCAS (by calculating estimators for the age effect) on baseline blood pressure 
data in HNR by computing expected blood pressure readings with the GEMCAS 
estimators and comparing these with the measured blood pressure readings in the 
5 year follow up. This has been done for men and women separately as follows:  
(a) Comparison of the 5 year and yearly changes of blood pressure readings 
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(1) For the HNR sample the 5 year cumulative changes of blood pressure 
readings were calculated by subtracting the individual 5 years follow up 
(t1) with the baseline (t0) readings as follows:  
ΔSBP = SBPt1– SBPt0  
ΔDBP = DBPt1 – DBPt0  
Means of ΔSBP and ΔDBP were computed to estimate the cumulative 5 
years mean changes in blood pressure (after 5 years of follow-up).  
(2) To obtain the mean yearly changes, the means of ΔSBP and ΔDBP were 
divided by five.  
ΔSBP = SBPt1– SBPt0 / 5 
ΔDBP = DBPt1 – DBPt0 / 5 
 
(b) Observed versus expected blood pressure readings in HNR 
(1) Effect estimators (ßs) for age on the systolic and diastolic blood pressure 
in GEMCAS have been computed by crude and multiple linear regression 
analyses, with age as the predictor and SBP or DBP as the outcome 
(Table 1). The analysis was done for the whole GEMCAS sample and 
separately for the subjects who were aged between 45 and 75 years to 
match with the age group of the HNR subjects. In order to perform an 
adjusted linear regression analyses following variables have been 
preselected as covariates: intake of antihypertensive medication, history 
of CVD, diabetes mellitus, intake of anti-diabetic medication, BMI, and 
smoking status.  
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Table 1: Linear regression models 
Variable  Crude model Adjusted model 
Dependent  SBP/DBP 
(mmHg) 
SBP/DBP (mmHg) 
Independent  Age in years Age in years 
Covariates  CVD history (yes/no) 
  Antihypertensive intake (yes/no) 
  Diabetes (yes/no) 
  Diabetic medication intake (yes/no) 
  BMI in kg/m2 
  Smoking (never/past/current smokers) 
reference: never smokers 
 
The linear regression model has been computed as follows 
Crude model: y = ß0 + ßage + Ɛ  
Fully adjusted model:  
y= ß0+ ßage+ ßCVD+ ßantihypertensives+ ßdiabetes+ ßanti-diabetic intake+ ßBMI + ßsmoking 
+ Ɛ  
Where y denotes the dependent variable (outcome) SBP respective 
DBP, ß0 the regression coefficient of the intercept, ßage the regression 
coefficient of the independent variable age (predictor), ßcovariate2-6 the 
regression coefficients of the covariates described in table 1 and Ɛ the 
error term. 
(2) The crude ßage achieved as described in (1) for both men and women, 
aged 45-75 years, were subsequently applied in the HNR sample to 
estimate expected blood pressure readings after five years. The ßage 
values were multiplied by 5 to get an estimated five year increase and 
added to the observed SBP or DBP readings at baseline. Observed 
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blood pressure readings are those measured for each HNR subject at 
baseline (t0) and 5 year follow up (t1): 
SBPexpected after 5 years = Observed SBPt0 + (5 x ßage) 
DBPexpected after 5 years = Observed DBPt0 + (5 x ßage) 
As the data were skewed and thus not perfectly normally distributed, the Wilcoxon 
signed rank test - a nonparametric test - was performed to assess whether the 
median ranks of expected and observed SBP/ DBP differed. The two sided 
significance level α has been set at 0.05, assuming differences with a p-value < 
0.05 as significant.  
However, the significance testing of these differences were the only 
statistical significance tests computing p-values in this work. Since it is well known 
that significance tests are sample size driven, even in sub-group analysis the tests 
of significance will be mostly positive in the GEMCAS study. Instead, 95% 
confidence intervals were reported to indicate the reliability of an estimate 
wherever appropriate. Additionally, the work was intended to present the 
distribution of blood pressure in a purely descriptive form.  
Since the effects of age and other covariates differed between men and 
women substantially, all analyses were done separately for men and women.  
All analyses have been carried out using SAS 9.2 version (SAS Institute, 
Cary, NC, USA). 
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Chapter 4  
Results  
4.1 Study characteristics of the GEMCAS subjects 
The characteristics of GEMCAS participants according to 10-year age-
classes are presented for men in Table 2 and for women in Table 3. GEMCAS 
included 35,869 subjects, 13,942  men (39%). As expected the prevalence of most 
risk factors increased with age. However, in both the sexes this increase can be 
observed only up to the age of 70 years and thereafter the risk factors showed a 
decreasing trend. Exceptions from this observation are the trend of SBP and blood 
glucose levels, which showed a continuous increase even up to the oldest age 
group (81-99 years) and smoking status, which decreases with increasing age. 
More than 60% of men and women aged >60 years were on antihypertensive 
therapy. At least 40% of men and women aged >70 years had a history of 
cardiovascular disease.  
The characteristics of the GEMCAS participants according to the JNC 7 
blood pressure classes are presented in Table 1 for men and Table 2 for women 
(Appendix B). Overall, the risk factors except current smoking status showed an 
increasing prevalence with increasing blood pressure. Age-standardization of the 
prevalence data also did not change this observation (Table 1 and 2, Appendix B)   
 
4.2 Frequency distribution and mean blood pressure 
Figures 1 and 2 depict the frequency distribution curves of the systolic and 
diastolic blood pressure readings stratified by 10-year age groups in men and 
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women respectively. Overall the absolute range of the diastolic readings is smaller 
than the range of the systolic readings. With increasing age, the curves of the 
systolic blood pressure show a flattening and a shift to the right, equating to higher 
blood pressure readings (figure 1). The shift to the right was more pronounced in 
women compared to men. In contrast, the diastolic blood pressure curves show 
only minimal changes by age in both sexes (figure 2).  
The mean BP across different age groups can be seen in the Figure 3. In 
both sexes the mean SBP and DBP showed a gradual increase with age 
especially up to 60 years, there after it remained almost constant. Men showed 
higher mean SBP values than women in the younger and middle age, however in 
the age group of 61-65 years there was a cross over in the mean SBP curves 
between men and women. The DBP mean values also showed an increase just 
similar to SBP in both men and women, reaching maximum values of 84 mmHg in 
men 50-55 years and 83 mmHg in women who were aged n 61-65 years. In 
contrast to SBP the mean DBP values showed a sharp decline in the older age 
groups in both sexes (figure 3). 
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Table 2: Characteristics of men in GEMCAS according to 10-year age classes  
 
 18-30 years 
(N=1,354) 
31-40 years 
(N=1,736) 
41-50 years 
(N=2,847) 
51-60 years 
(N=3,249) 
61-70 years 
(N=2,729) 
71-80 years 
(N=1,706) 
81-99 years 
(N=320) 
Age (years)  
 Mean (±SD) 
 
24.4±3.7 
 
36.1±2.8 
 
45.6±2.8 
 
55.5±2.7 
 
65.8±2.7 
 
74.7±2.7 
 
83.7±3.0 
Weight (Kg) 
 Mean (±SD) 
 
80.6±15.1 
 
86.9±15.4 
 
88.4±16.0 
 
88.4±14.9 
 
86.6±13.4 
 
82.8±12.3 
 
77.8±11.6 
BMI (%)        
18-<25 25 kg/m
2
 62.2 38.0 31.1 22.4 19.2 23.4 35.9 
25 - < 30 kg/m
2
 27.0 42.0 44.1 48.0 51.6 51.7 48.4 
≥ 30 kg/m
2
 10.8 20.0 24.8 29.6 29.2 24.9 15.6 
Waist circumference (cm) 
Mean (± SD) 
 
86.8±12.6 
 
93.9±12.2 
 
98.2±12.9 
 
101.6±12.4 
 
102.7±11.6 
 
102.6±12.9 
 
100.9±10.8 
Lipid Profile        
Total Cholesterol (mg/dl)  
Mean( ± SD) 
 
174.2±37.2 
 
201.6±39.8 
 
213.2±42.7 
 
208.8±44.4 
 
205.1±39.4 
 
198.5±38.2 
 
193.3±39.5 
HDL (mg/dl) 
Mean( ± SD) 
 
52.3±11.7 
 
52.7±13.1 
 
53.9±14.7 
 
54.6±14.4 
 
55.6±14.5 
 
55.4±14.4 
 
55.7±16.0 
LDL (mg/dl) 
Mean (± SD) 
 
107.4±33.4 
 
128.4±35.9 
 
136.3±37.8 
 
130.8±35.8 
 
129.6±35.7 
 
124.3±34.2 
 
120.6±34.2 
Triglycerides (mg/dl) 
 Median (Q1; Q3) 
 
108(76;160) 
 
140(95;209) 
 
153(103;231) 
 
155(106;239) 
 
148(105;215) 
 
139(100;194) 
 
126(90;185) 
Blood Pressure (BP)        
Systolic BP (mmHg) 
Mean (± SD) 
 
123.8±14.7 
 
126.5±14.7 
 
130.5±16.8 
 
135.1±17.7 
 
139.2±18.6 
 
140.5±19.0 
 
141.7±19.0 
Diastolic BP (mmHg) 
Mean (± SD) 
 
77.2±10.0 
 
80.1±9.8 
 
82.6±10.7 
 
83.1±10.2 
 
81.9±10.2 
 
80.3±10.6 
 
79.0±10.7 
Blood glucose (mg/dl) 
Mean (± SD) 
 
85.7±17.5 
 
90.9±21.9 
 
97.9±32.0 
 
108.3±41.1 
 
111.1±39.7 
 
113.0±39.8 
 
119.0±47.3 
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Table 2 (cont.): Characteristics of men in GEMCAS according to 10 year age classes  
 
Risk Factor 18-30 years 
(N=1,354) 
31-40 years 
(N=1,736) 
41-50 years 
(N=2,847) 
51-60 years 
(N=3,249) 
61-70 years 
(N=2,729) 
71-80 years 
(N=1,706) 
81-99 years 
(N=320) 
Smoking status (%)        
Current Smoker 49.3 39.0 37.8 26.6 13.4 9.3 4.5 
Past Smoker 13.0 23.4 32.3 44.7 52.4 56.5 63.1 
Never Smoker 37.7 37.6 29.9 28.7 34.2 34.2 32.4 
Pharmacotherapy (%)        
Anti-diabetic 1.1 2.4 6.4 15.1 20.0 20.1 18.8 
Antihypertensive 4.4 11.1 25.1 47.0 65.5 75.0 80.6 
Lipid lowering 0.6 3.7 10.2 21.7 31.6 29.3 29.4 
Comorbidities (%)        
Cardiovascular diseases 1.0 2.2 8.2 21.1 36.0 50.3 63.9 
Diabetes (Self reported) 0.8 3.0 8.6 20.3 26.1 27.5 26.2 
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Table 3: Characteristics of women in GEMCAS according to 10 year age classes  
 
Risk Factor 18-30 years 
(N=2,641) 
31-40 years 
(N=3,330) 
41-50 years 
(N=4,969) 
51-60 years 
(N=4,677) 
61-70 years 
(N=3,422) 
71-80 years 
(N=2,257) 
81-99 years 
(N=630) 
Age (years)  
 Mean (±SD) 
 
24.1±3.7 
 
36.2±2.8 
 
45.4±2.9 
 
55.3±2.8 
 
65.7±2.8 
 
75.0±2.8 
 
83.9±3.1 
Weight (Kg) 
 Mean (±SD) 
 
66.9±15.6 
 
70.6±16.1 
 
71.6±15.8 
 
74.4±15.6 
 
74.9±13.7 
 
72.7±12.5 
 
70.0±11.4 
BMI (%)        
≤ 25 kg/m
2
 71.9 60.3 52.7 37.2 28.9 27.7 42.5 
25 - < 30 kg/m
2
 16.7 23.2 27.1 33.7 39.9 41.4 39.6 
≥ 30 kg/m
2
 11.4 16.5 20.2 29.2 31.2 30.9 17.9 
Waist circumference (cm) 
Mean (± SD) 
 
77.7±12.7 
 
82.0±13.4 
 
84.9±13.9 
 
89.8±14.3 
 
92.5±13.0 
 
93.1±11.9 
 
89.7±11.3 
Lipid Profile        
Total Cholesterol (mg/dl)  
Mean( ± SD) 
 
182.9±34.1 
 
188.0±33.1 
 
205.4±36.6 
 
222.9±39.9 
 
225.8±41.0 
 
219.7±40.4 
 
218.9±42.2 
HDL (mg/dl) 
Mean( ± SD) 
 
66.8±16.6 
 
66.7±16.7 
 
67.7±17.3 
 
68.5±18.0 
 
67.3±17.2 
 
65.1±16.6 
 
66.2±17.6 
LDL (mg/dl) 
Mean (± SD) 
 
105.8±30.4 
 
111.3±29.8 
 
125.1±34.1 
 
138.6±36.7 
 
141.7±36.5 
 
136.9±36.9 
 
136.0±37.0 
Triglycerides (mg/dl) 
 Median (Q1; Q3) 
 
95(70;131) 
 
93(68;133) 
 
104(74;150) 
 
124(89;180) 
 
136(100;192) 
 
139(104;193) 
 
135(102;176) 
Blood Pressure (BP)        
Systolic BP (mmHg) 
Mean (± SD) 
 
115.5±13.2 
 
118.4±14.5 
 
124.2±16.7 
 
131.9±18.1 
 
138.7±18.7 
 
141.6±19.6 
 
142.2±20.3 
Diastolic BP (mmHg) 
Mean (± SD) 
 
73.6±9.5 
 
76.1±10.0 
 
79.0±10.5 
 
81.3±10.3 
 
82.4±10.1 
 
81.2±10.7 
 
79.2±10.7 
Blood glucose (mg/dl) 
Mean (± SD) 
 
82.5±13.2 
 
85.7±15.2 
 
90.7±22.7 
 
97.8±30.8 
 
102.6±32.6 
 
107.8±39.1 
 
112.0±41.6 
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Table 3 (cont.): Characteristics of women in GEMCAS according to 10 year age classes  
 
Risk Factor 18-30 years 
(N=2,641) 
31-40 years 
(N=3,330) 
41-50 years 
(N=4,969) 
51-60 years 
(N=4,677) 
61-70 years 
(N=3,422) 
71-80 years 
(N=2,257) 
81-99 years 
(N=630) 
Smoking status (%)        
Current Smoker 41.0 31.2 31.3 21.6 8.7 5.0 2.2 
Past Smoker 14.9 20.5 26.4 25.6 22.7 19.2 15.4 
Never Smoker 44.1 48.3 42.3 52.8 68.6 75.8 82.4 
Pharmacotherapy (%)        
Anti-diabetic 0.5 1.2 2.7 7.4 13.6 18.0 19.7 
Antihypertensive 3.1 7.5 19.8 40.1 60.7 77.0 79.4 
Lipid lowering 0.4 1.0 3.3 11.6 23.0 28.1 20.3 
Comorbidities (%)        
Cardiovascular diseases 0.7 1.8 3.7 9.1 20.3 39.7 51.9 
Diabetes (Self reported) 0.6 2.0 4.2 10.9 18.3 25.9 26.6 
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Figure 1: Frequency distribution of systolic blood pressure by sex 
 
The bars on top of each graph indicate the proportion of subjects of the total sample 
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Chapter 4. Results 
    43 
Figure 2: Frequency distribution of diastolic blood pressure by sex  
 
The bars on top of each graph indicate the proportion of subjects of the total sample 
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Figure 3: Mean systolic and diastolic blood pressures by age-groups and 
sex, whole study sample  
 
 
 
 
4.3  Percentile blood pressure distribution  
 
4.3.1 Percentile distribution of systolic blood pressure 
The percentile distribution of SBP is depicted in Figure 4. Since the 
distribution differed between women and men, the distribution for women and men 
are separately presented here (figure 4). The illustration of the overall distribution 
– thus not only the mean – can be viewed from two perspectives: (1) possible 
differences of the blood pressure range between age categories, and (2) course of 
an age-related increase in blood pressure in each part of the distribution.  
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(1) The range of systolic blood pressure does not proceed in parallel 
between the percentile bands; instead, the spread between the 5th and the 95th 
percentile increases with increasing age: the systolic blood pressure of the 
youngest women aged 18-25 ranges between 95-136 mmHg (Δ +41 mmHg) and 
rises to 110-180 mmHg (Δ +70 mmHg) in the older women (81-85 years). Overall, 
the ratio between the lowest 5th and highest 95th percentile ranges between 1.43 
and 1.64 (figure 4). A similar observation can be made in men, with blood pressure 
readings ranging between 100-150mmHg in the youngest men and 115-180 
mmHg in the older age group (figure 4), and ratios ranging between 1.50 in 
younger (18-25 years) and 1.57 in older men (81-85 years).  
(2) What seems striking is that in all percentiles, even the lowest, a gradual 
increase in blood pressure with increasing age was observed (figure 4). It could be 
observed from the graph that, all the SBP percentiles showed a shift in their values 
as the age advanced especially until the 65th year or so. From the age of 66, the 
shifts in the SBP percentiles were minimal in the successive age groups. In 
women, the difference in the lowest 5th percentile between younger and older 
women was around +15mmHg (95–110mmHg) and between 20-32 mmHg in the 
25th and 75th percentile, rising to +40 mmHg in the 95th percentile (136-180 
mmHg). A similar observation can be made in men, in this case with a more 
constant increase of +20 mmHg in all percentiles with the exception of young men 
(+10 mmHg for 5th percentile). Although women had lower SBP values in the 
younger ages when compared to men, after the age-class 55-60 years the SBP 
percentiles in both sexes were almost similar. 
Lastly, half of all the women in our study sample had by the age of 30 
already had to be classified according to their systolic blood pressure at least as 
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prehypertensive according to JNC VII classification of blood pressure (Chobanian 
2003). In men this situation is even more pronounced, with all men, even the 
youngest age group, having to be classified at least as prehypertensive. In men 
and women who were over the age class of 66-70 years, half of them had a 
systolic blood pressure in the hypertensive range.  
 
4.3.2 Percentile distribution of diastolic blood pressure 
The percentile distribution of SBP is depicted in Figure 5. When compared 
to the systolic blood pressure, a different picture emerges with regard to the 
diastolic blood pressure distribution. Overall, in both women and men a slight 
increase in the diastolic blood pressure can be observed, reaching a plateau 
between 40 and 60 years and decreasing slightly thereafter (figure 5). However, a 
detailed analysis of the age course of the different percentiles reveals some 
notable differences. For instance, in women in the lowest 5th percentile of the 
blood pressure readings we observed a constant blood pressure of 60 mmHg up 
to the age of 50 (figure 5). An increase in this percentile of the diastolic blood 
pressure by 10 mmHg only occurred within a 15-year period (51-65 years). 
Thereafter, the 5th percentile of diastolic blood pressure decreased again within 10 
years to 60 mmHg. A similar course was observed in the 25th percentile. All other 
percentiles differ in their course by an earlier increase, a more prolonged plateau 
and a marginal decrease, if any, in the highest age groups. It is striking that the 
median changed only up to the age of 41-45 years and remained constant at 80 
mmHg after that time. This is even more striking in men, where in any age group 
the median blood pressure was 80 mmHg (figure 5).  
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Overall it seems that low diastolic blood pressure readings are associated 
with greater age-related changes. 
Figure 4:  Percentile Distribution of systolic blood pressure by Sex and Five 
Year Age-Groups  
The delta indicates the approximate increase of blood pressure in each percentile 
between the younger and older age-groups. 
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Figure 5:  Percentile Distribution of the diastolic blood pressure by Sex and 
Five Year Age-Groups  
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4.3.3 Sensitivity Analyses  
 
Sensitivity analyses were performed to test whether antihypertensive 
medication and CVD risk factors alter the observations of the blood pressure 
distribution described above. 
Overall, the systolic blood pressure distributions of the subgroups were similar to 
the full study sample, i.e. we observed increasing systolic blood pressure 
measurements by age in each percentile in both sexes (Figure 6 a-d). However, 
the absolute differences varied. For example, in men we observed a maximum 
increase of +20 mmHg in the systolic blood pressure between younger and older 
age-groups in the lowest percentile. This can be observed even in the subsample 
with no antihypertensive intake and CVD risk factors (figure 6 c-d), which is twice 
as high as in the study sample as a whole. All other percentiles in men showed an 
increase of +20 mmHg even in the absence of CVD risk factors and 
antihypertensive intake (figure 6c-d).  In women, the maximum increase in systolic 
blood pressure was rather higher in all percentiles compared to men, with nearly 
45 and 55 mmHg rise in the 95th percentiles (figure 6a-b). Although there was not 
much of an age related shift of SBP percentiles in the younger ages (< 45 years), 
there is an obvious shift in the middle and old ages, especially between 46 and 85 
years in both the sexes.  
As expected, the absolute systolic blood pressure measurements were 
lower in the “healthy” subgroup of participants with no CVD and no CVD risk 
factors compared to those with CVD and CVD risk factors. However, women in the 
lowest percentile (5th) had very similar absolute readings (90-110 mmHg) 
independent of their risk factor status (figure 4, figure. 6a-b). 
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With regard to the diastolic blood pressure, the sensitivity analysis did not 
alter the observations described above of the study sample as a whole, with the 
exception that in women the observed increase in the lower percentile began later 
(>51 years in women of the full study sample, >56 years without antihypertensive 
medication, >61 years without CVD and CVD risk factors). However, it may be 
worth noting that (a) compared to the full study sample, the diastolic blood 
pressure measurements in women were only slightly higher and in men almost 
identical to or in some cases even lower than those in the subgroup of participants 
without intake of antihypertensive medication (figure 7a-d); and (b) especially in 
men the median of all age groups was almost exactly 80 mmHg independent of 
the kind of risk group. 
 
Chapter 4. Results 
    52 
Figure 6: Percentile Distribution of the systolic blood pressure by five year 
age-groups and sex; (A) Women without antihypertensive intake, 
(B) Women without antihypertensive intake and no CVD risk 
factors.  
 The delta indicates the approximate increase of blood pressure in each percentile 
between the younger and older age groups  
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Figure 6: Percentile Distribution of the systolic blood pressure by five year 
age-groups and sex; (C) Men without antihypertensive intake, (D) 
Men without antihypertensive intake and no CVD risk factors.  
The delta indicates the approximate increase of blood pressure in each percentile 
between the younger and older age groups  
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Figure 7: Percentile Distribution of the diastolic blood pressure by five year 
age-groups and sex; (A) Women without antihypertensive intake, 
(B) Women without antihypertensive intake and no CVD risk 
factors 
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Figure 7: Percentile Distribution of the diastolic blood pressure by five year 
age-groups and sex; (C) Men without antihypertensive intake, (D) 
Men without antihypertensive intake and no CVD risk factors.  
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4.4 Validation of the observed age effects 
4.4.1 Study characteristics of GEMCAS and Heinz Nixdorf Recall 
study subjects 
A comparison of the study populations of the Heinz Nixdorf Recall study 
and the GEMCAS subsample restricted to participants aged 45-75 years is 
presented in Table 4. Men of the HNR sample were slightly more often overweight 
(54%) or obese (26.6%) compared to men of the GEMCAS subsample (48.9% 
resp. 28.6%). In women it was the opposite with 65.6% women in HNR being 
either overweight or obese compared to 67.6% women in GEMCAS. However, the 
mean WC for both men and women were higher in the GEMCAS subsample than 
in the HNR subjects. Overall, the GEMCAS subsample in both sexes had a better 
lipid profile compared to the HNR with lower means for total cholesterol, LDL, and 
higher means for HDL. Men in HNR had a higher mean SBP and DBP (138.0 
mmHg, 83.9 mmHg) compared to the GEMCAS subsample (136.3 mmHg, 82.4 
mmHg), In spite of a higher proportion of women in GEMCAS taking 
antihypertensive therapy compared to HNR women (45.6 % in GEMCAS, 38.4% in 
HNR) the mean SBP and DBP (133.4 mmHg and 81.2 mmHg) of GEMCAS 
women compared to the HNR women (128.4 mmHg and 79.0 mmHg). The mean 
blood glucose concentration was higher in HNR subjects compared to the 
GEMCAS subsample: 6.4 mmol/L in HNR and. 6.0 mmol/l in GEMCAS for men 
and 6.0 mmol/l in HNR and 5.5 mmol/l in GEMCAS for women. The anti-diabetic 
medication intake of HNR subjects was nearly half that of the GEMCAS sub 
sample.  Nearly 7.3% men and 4.6% women from HNR were taking anti-diabetic 
medications compared to 15.7% men and 9.3% women from the GEMCAS sub 
sample. Men and women from the HNR cohort smoked more when compared to 
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the GEMCAS subsample. About 46.3% men in HNR and 22.7 % men in 
GEMCAS, 23.1% women in HNR and 18.8% women in GEMCAS smoked at the 
time of the study. The intake of antihypertensive and lipid lowering medications 
was also higher in GEMCAS subsample men (52.4% and 23.9% respectively) and 
women (45.6% and 15.0 % respectively) compared to the men (37.9% and 15.1% 
respectively) and women (34.8% and 11.3% respectively) in the HNR cohort. As 
expected from a patient based sample out of primary care practices compared to a 
population based sample, Men (26.6% in GEMCAS and 10.9% in HNR) and 
women (14 % in GEMCAS and 2.8% in HNR) in the GEMCAS subsample reported 
more of a history of CVD compared to HNR cohort.  
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Table 4. Comparison of GEMCAS and Heinz Nixdorf Recall (HNR) study 
subjects by sex, both aged 45-75 years 
 MEN WOMEN 
 GEMCAS 
(n=8,774) 
HNR 
(n=2,395) 
GEMCAS 
(n=12,325) 
HNR 
(n=2,419) 
Age (years)  
Mean (±SD) 
59.1± 8.6 59.7± 7.8 58.2± 8.7 59.6± 7.8 
BMI     
≤ 25 kg/m
2
  22.5 19.4 36.4 34.4 
25 - < 30 kg/m
2
 48.9 54.0 39.0 37.2 
≥ 30 kg/m
2
 28.6 26.6 28.6 28.4 
Waist circumference (cm) 
Mean (± SD) 
 
101.6± 12.2 
 
100.3± 10.8 
 
90.1± 13.9 
 
88.5± 12.9 
Lipid Profile     
Total Cholesterol (mmol/l) 
Mean ( ± SD) 
 
5.4 ± 1.1 
 
5.8 ± 0.99 
 
5.7 ± 1.0 
 
6.0 ± 1.02 
HDL (mmol/l) 
Mean (± SD) 
 
1.4 ± 0.38 
 
1.3 ± 0.37 
 
1.8 ± 0.45 
 
1.7 ± 0.44 
LDL (mmol/l)  
Mean ( ± SD) 
 
3.4 ± 0.94 
 
3.8 ± 0.92 
 
3.5 ± 0.94 
 
3.8 ± 0.95 
Triglycerides (mmol/l) 
median (Q1; Q3) 
 
1.7 (1.2;2.6) 
 
1.6 (1.1;2.3) 
 
1.7 (1.0;2.0) 
 
1.3 (1.0;1.8) 
Blood Pressure (BP)     
Systolic BP (mmHg)  
Mean (± SD) 
 
136.3 ± 18.3 
 
138.0 ± 19.5 
 
133.4± 18.9 
 
128.4 ± 21.1 
Diastolic BP (mmHg)  
Mean (± SD) 
 
82.4 ± 10.3 
 
83.9 ± 10.6 
 
81.2 ± 10.4 
 
79.0 ± 10.6 
Fasting Blood glucose 
(mmol/l)  
Mean ( ± SD) 
 
6.0 ± 2.21 
 
6.4 ± 1.75 
 
5.5 ± 1.75 
 
6.0 ± 1.34 
Smoking status (%)     
Current Smoker 22.7 46.3 18.8 23.1 
Past Smoker 46.2 25.7 24.7 21.2 
Never Smoker 31.1 28.0 56.5 55.7 
Pharmacotherapy (%)     
Anti-diabetic 15.7 7.3 9.3 4.6 
Antihypertensive 52.4 37.9 45.6 34.8 
Lipid lowering 23.9 15.1 15.0 11.3 
Comorbidities (%)     
Cardiovascular disease 26.6 - 14.0 - 
Diabetes (self reported) 20.9 9.8 13.0 6.7 
Coronary artery disease - 10.9 - 2.8 
- data not obtained 
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4.4.2 Linear regression analyses  
The effects of age upon blood pressures for the GEMCAS subjects are 
presented in Table 5. In a first crude model linear regression was computed using 
systolic blood pressure or diastolic blood pressure as outcome and age as the 
predictor.  
Age showed an effect on SBP in both sexes, and women had a higher 
effect of age on SBP with a ß value of 0.555 compared to men with a ß value of 
0.355. After adjusting for antihypertensive medication, history of CVD, diabetes, 
smoking and BMI, the effect of age on SBP was still observable and also higher in 
women compared to men with ß values of 0.402 and 0.267 for women and men 
respectively.  
Age showed an effect also on the DBP in both sexes, and women had a 
higher effect of age on DBP with a ß value of 0.154 compared to men with a ß 
value of 0.04 after adjustment for the above mentioned risk factors the effect of 
age upon DBP still persisted, even after adjustment women showed higher effects 
of age upon DBP compared to men, with ß values of 0.104 and 0.019 respectively 
for women and men (Table 5).  
 In subgroup analyses the same models as above were used, but the 
analyses was restricted the age group of 45 - 75 years. 
Compared to the whole sample, the age effect on SBP was slightly higher 
for both men and women in the subgroup. Similar to the whole sample, the age 
effects on SBP were higher in women compared to men in the crude model with ß 
values of 0.651 and .0.385 for women and men respectively. After adjustment, the 
age effect in women markedly decreased, but was still higher compared to the age 
effect on SBP in men with ß values of 0.489, and 0.319 for women and men.  
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With regard to men and women aged between 45 and 75 years, contrasting 
effects of age were observed upon the DBP. In men, the diastolic blood pressure 
decreased with age (ß= -0.085), the decreasing effect remained even after 
adjustment (ß= -0.102). Whereas in women, a positive effect of age on DBP was 
observed (ß=0.096), which was still observable even after adjustment (ß=0.0420) 
(Table 5).  
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Table 5. Effect of age upon blood pressure for the GEMCAS subjects. 
          Whole sample Subjects aged 45-75 years 
 Men Women Men Women 
 ß (SE)       P >t  
 
 ß (SE)        P >t ß (SE)        P >t  ß (SE)       P >t 
SBP  
Unadjusted  
Age 0.355 (0.009)  <0.0001 0.555 (0.007)  <0.0001 0.385 (0.022)  <0.0001 0.651 (0.019)  <0.0001 
Adjusted*  
Age 0.267 (0.011) <0.0001 0.402 (0.009)  <0.0001 0.319 (0.024)   <0.0001 0.489 (0.021) <0.0001 
DBP  
Unadjusted  
Age   0.040 (0.006) <0.0001 0.154 (0.004)  <0.0001 -0.085 (0.013)  <0.0001 0.096 (0.010) <0.0001 
Adjusted*  
Age   0.019 (0.006)   0.005 0.104 (0.005)  <0.0001 -0.102 (0.015)   <0.0001 0.0420 (0.013)   0.008 
SBP, Systolic blood pressure; DBP, Diastolic blood pressure; ß, effect estimator for age; SE, Standard Error; P >t,  P Value; 
*Adjusted for: antihypertensive medication, CVD history, diabetes, anti-diabetic medication, smoking, BMI 
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4.4.3 Five year differences of blood pressure values in Heinz Nixdorf 
Recall subjects 
The blood pressure differences for HNR subjects between baseline (t0) and 
five year follow-up (t1) are presented in Table 6. The cumulative mean difference 
of the systolic blood pressure (Δ SBPt1-t0) was higher in women (+2.87 mmHg) 
compared to men (+0.51 mmHg). The cumulative mean DBP (Δ DBPt1-t0) declined 
more in men (-3.21mmHg) compared to women (-1.52 mmHg) between baseline 
and 5-year follow up.  
In a sub-group analysis of “healthy” study participants – excluding 
participants (93% of the whole sample) with diabetes, CAD, overweight, intake of 
antihypertensive and/or anti-diabetic medications, a history of smoking or current 
smokers – the difference of the systolic BP between follow-up and baseline was 
even higher in both women and men (ΔSBPt1-t0: +6.65 mmHg, respective +2.08 
mmHg) compared to the whole study sample. With regard to the diastolic blood 
pressure the cumulative mean DBP in this very specific “healthy” group declined in 
men by -2.0 mmHg, which is similar to the whole study sample, but increased in 
women by +0.52 mmHg, which is an opposite trend compared to the whole study 
sample of women.  
 
4.4.4  Expected versus observed blood pressure readings in the Heinz 
Nixdorf Recall Study 
The expected and observed means of blood pressure readings in HNR 
subjects are presented in Table 7. Despite the different study characteristics of 
both GEMCAS and Heinz Nixdorf Recall, the expected and observed blood 
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pressures readings were surprisingly alike, with only slightly higher observed than 
expected blood pressures in both sexes and irrespective of the risk factor status. 
In women the difference was only 0.9 mmHg (131.3 mmHg resp. 130.4 mmHg), 
which was despite the high sample size not significant. In men the expected and 
observed values differed by 1.8 mmHg (139.7 mmHg to 137.9 mmHg).  
The difference between expected and observed was higher with regard to 
the DBP. Here in men differences of 2.9 mmHg (83.7 mmHg to 80.8 mmHg), and 
in women 2.1 mmHg (79.5 mmHg to 77.4 mmHg) were observed. 
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Table 6.  Mean BP differences in HNR study subjects between baseline and 5-year follow up, by sex 
 
 Complete HNR cohort 
(N=4,814) 
HNR Sub-sample* 
(N=310) 
 Men 
[mmHg] 
Women 
[mmHg] 
Men 
[mmHg] 
Women 
[mmHg] 
Δ SBPt1-t0 (mean ± SD)     
Cumulative (5 years) 0.51 (±19.30) 2.87 (±19.52) 2.10 (±11.98) 6.65 (±16.27) 
Yearly (year) 0.10 (±3.86) 0.57 (±3.90) 0.42 (±2.40) 1.33 (±3.25) 
Δ DBPt1-t0 (mean ± SD)     
In 5 years -3.21 (±11.07) -1.52 (±10.46) -2.00 (±8.69) 0.51 (±8.78) 
Yearly (year) -0.64 (±2.21) -0.34 (±2.09) -0.40 (±1.74) 0.10 (±1.76) 
*No CAD history, no diabetes, no smoking history, normal BMI, no intake of antihypertensive and anti-diabetic medications  
 
Table 7: Expected and observed blood pressures HNR 
 Men 
(N= 2,384) 
Women 
(N=2,415) 
 Expected   Observed 
 
P value Expected   Observed 
 
P value 
Mean (± SD) SBP (mmHg) 139.7 (±19.5) 137.9 (±19.2) - 131.3(±20.8) 130.4 (±19.9) - 
Mean (± SD) DBP (mmHg) 83.7 (±10.6) 80.8 (±10.8) - 79.5 (±10.3) 77.4 (±10.0) - 
Median SBP ( mmHg) 138.4 137.0 0.038 128.8 128.5 0.988 
Median DBP ( mmHg) 83.1 80.0 <0.0001 79.0 77.0 <0.0001 
- Not computed  
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Chapter 5 
Discussion  
 
This work was aimed (a) to analyse the distribution of the systolic and 
diastolic blood pressure in a German healthcare population with regard to age, sex 
and cardiovascular risk factors, and (b) to examine if age related effects on blood 
pressure observed in a cross-sectional study could be reproduced in an 
independent longitudinal study.  
This study provides for the first time, detailed descriptive estimates of the 
distribution of the systolic and diastolic blood pressure for both sexes and for a 
wide age range of age, taking into account individuals with and without CVD and 
CVD risk factors. The application of percentiles rather than one single measure of 
location - e.g. the arithmetic mean - combines aspects of ordered data and 
cumulative frequencies. Together with the large sample size of 35,869 participants 
of GEMCAS, it was possible to perform a percentile distribution for men and 
women at the age of 18 to 99 years and to learn more about the full range of blood 
pressure variation, especially in the borderline range.   
In the first section of the discussion (5.1) key findings of the study will be 
summarized. In the following sections (5.2) the mean blood pressure readings will 
be discussed, followed by a detailed discussion of percentile distribution of blood 
pressure (5.3) and sensitivity analyses (5.4). Section (5.5) discusses the validation 
of the effects of age. The discussion chapter closes with an overview of strengths 
and limitation of the work (5.6) followed by the conclusion (5.7). 
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5.1 Key findings 
In both sexes the mean systolic and diastolic blood pressure showed the 
well-known gradual increase with age especially up to the age of 60 years, 
followed by a flattened course of the systolic and an almost constant course of the 
diastolic blood pressure. 
A consistent increase of the systolic blood pressure with age was not only 
restricted to the mean blood pressure readings, but could also be observed in all 
percentiles examined. Even in the lowest percentile (5th) a gradual increase from 
the age-group <25 to >80 years of about 10 mmHg in men, in all other percentile 
groups an increase of 20 mmHg. Accordingly, as women exhibit lower blood 
pressures in younger and cross men in middle age their increases form the 
youngest to the higher age-groups ranged from 15 mmHg (5th) to 40 mmHg (95th).  
Furthermore, the ranges between the 5th and 95th SBP percentiles in the 
youngest and the oldest age groups varied considerably in both sexes and did not 
proceed in parallel with age. The range of the 5th - 95th SBP percentile was 100-
150 mmHg in the youngest age group and 115-180 mmHg in the oldest age group 
in men. Whereas in women, the ranges were 95-136 mmHg and 110-180 mmHg 
for the youngest and the oldest age groups. 
In men without any antihypertensive therapy, an increase of 20 mmHg of 
the SBP between the youngest and the oldest age groups was observed. In 
women an increase of at least 20 mmHg could be observed in all percentiles 
between the youngest and the oldest age groups. Except in the 5th percentile a 
lower increase was observed (11 mmHg). A similar increase between the 
youngest and the oldest age groups was observed in a subpopulation of “healthy” 
subjects without any history of CVD and/or any CVD risk factors: all percentiles 
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showed an increase of at least 15 mmHg of SBP in men, in women the increase 
was at least 25 mmHg in all the percentiles except the 5th percentile (10 mmHg).  
The DBP percentiles showed a different picture when compared to the SBP, 
as the age related differences in the percentiles were minimal irrespective of the 
occurrence of cardiovascular risk factors. Overall it seemed that low diastolic blood 
pressure readings are associated with greater age-related changes. 
The age related changes in the blood pressure observed in the cross 
sectional data from the GEMCAS sample could also be observed in the 
longitudinal Heinz Nixdorf Recall study. Although the rise in blood pressures with 
respect to age was slightly different in both studies, a definite age related shift was 
observed in both the samples and this age related shift was independent of the 
occurrence of cardiovascular risk factors.  
Overall an increase of the SBP of 0.10 mmHg/year in men and 0.57 
mmHg/year in women could be observed in the Heinz Nixdorf Recall study after 
five years during the follow up examination. In the sub-sample of subjects without 
CVD risk factors the increases were 0.42 mmHg/year and 1.33 mmHg/year for 
men and women respectively. 
In the HNR study cohort, the mean expected SBP (calculated by data of the 
GEMCAS sample) was only slightly higher than the mean observed SBP in both 
men (1.8 mmHg) and women (0.9 mmHg). The expected mean DBP was higher 
than the observed mean DBP in both sexes.  
Thus our data suggest that an age-related increase in systolic blood 
pressure occurs independently of known associated factors for elevated blood 
pressure as part of an age-relating process. 
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5.2 Age related changes in blood pressure 
The effects of age upon blood pressure were studied extensively both in 
cross- sectional studies (Joffres et al. 1992, Plans 1993, Burt et al. 1995, Banegas 
1998, Thamm 1999) and longitudinal studies (Harlan et al. 1962, Landahl et al. 
1986, Pearson et al. 1997). Age related changes in blood pressure when studied, 
showed that the blood pressure differences between men and women were most 
obvious in young, middle ages, but in the later ages the differences narrowed 
down (Whelton 1994). GEMCAS study results with respect to mean blood 
pressure in different age classes in Germany were almost in concordance to a 
previous nationwide German study conducted in 1998 (Thamm 1999). Both 
studies showed that the mean SBP and DBP values in men were clearly higher 
than women in young and middle ages but the values did not differ much after 60 
years of age. A similar trend for mean SBP was also observed in other studies 
(Joffres et al. 1992, Plans et al. 1993, Asmar et al. 2001, Primatesta et al. 2001, 
Azizi et al. 2002,). 
The SBP in women crossed the SBP level in men around the age of 60 
years which is well in line to other studies (Plans et al. 1993, Azizi et al. 2002, 
Wilkins et al. 2010). This cross-over and thus higher blood pressures in women 
compared to men are probably due to the fact that men with higher blood pressure 
values have a higher mortality rate than women especially in the older ages. This 
is a major problem when data from cross-sectional studies are analysed. This 
selective survival of men with lower blood pressure and higher mortality of men 
with higher blood pressure might lead to a less proportional representation of men 
in the cross-sectional surveys and thereby might lead to underestimation of the 
effect of age on systolic and diastolic blood pressure. Although, the selective 
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survivorship has been the most widely postulated concept with cross-sectional 
studies, this concept has been challenged by Franklin et al. 1997. In their analyses 
of the blood pressure data from the Framingham study they found that, even when 
all deceased participants and patients with non-fatal myocardial infarction or 
congestive heart failure were removed from their study sample, the late decline of 
the diastolic blood pressure was still present (Franklin et al. 1997). 
 
5.3 Percentile distribution of blood pressure  
Many studies in the past examined the blood pressure distribution in 
different populations across the world (Joffres et al. 1992, Plans et al. 1993, Wolf 
et al. 1997, Banegas et al. 1998, Thamm 1999, Asmar et al. 2001, Wolf-Maier et 
al. 2003, Wang, Wang 2004, Choi et al. 2006, Yadav et al. 2008, Erem et al. 2009,  
Wilkins et al. 2010). However, very few studies analyzed the percentile distribution 
of blood pressure in the population and even less with respect to age, sex and 
cardiovascular risk factors (Acheson 1973, Pobee et al. 1977, Lim et al. 2000, 
Azizi et al. 2002, Wright et al. 2011).  
A study from Acheson (1973) described the distribution of the systolic and 
diastolic blood pressure in a nationwide sample of 6,546 subjects of the two 
largest racial groups in the United States, aged 18-79 years.  As in our study, the 
data of this survey showed the same age-related increase in the systolic blood 
pressure even in the 5th percentile. Compared to our study sample, the absolute 
readings and age-related increases in the blood pressure readings were 
considerably higher (as expected especially in the higher blood pressure ranges), 
the latter ranging from 16 mmHg in the 5th percentile to 73 mmHg in the 95th 
percentile in women (men: 10-57 mmHg); In GEMCAS we found (taking into 
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account the maximum age of 79 years): 15-41 mmHg in women; 10-20 mmHg in 
men, cf. figure 4). However, this survey was conducted more than 50 years ago. 
Recent NHANES data representing the period 2001-2008 and including 19,921 
participants reported much lower blood pressure readings (Wright et al. 2011). 
They reported an age-related increase in blood pressure readings ranging from 13 
mmHg in the 5th percentile to 53 mmHg in the 95th percentile in women, in men this 
was only 2 mmHg in the 5th percentile and 31 mmHg in the 95th percentile. With 
the exception of the low increase in men in the 5th percentile, these recent data are 
in line with the observation made in GEMCAS study (Wright et al. 2011). 
. The increase of SBP with respect to age in the study of Acheson was 
comparatively higher than in GEMCAS, especially observable in the higher 
percentiles. Acheson reported that half of all men had a SBP of at least 120 mmHg 
by the age of 18 years. This means to say that under the current guidelines for 
definition of hypertension, at least half of the men were prehypertensive by the age 
of 18 years, which is similar to men in the GEMCAS study.  
Pobee et al. (1977) in their study observed the blood pressure distribution in 
Ghanaian population, comprising 1,670 subjects who were 16 years and older. 
Similar to GEMCAS they also found that in most of the age groups of their study 
population the mean blood pressure was higher than the median value. They 
additionally reported an age related increase of SBP in women of at least 20 
mmHg between the youngest (15-24 years) and the oldest age groups (>75 
years). Whereas in men a considerable age related SBP increase was observed 
only in the 75th and 95th percentiles between the youngest and the oldest age 
groups (Pobee et al. 1977). Although the study results from Pobee et al. were 
comparable to GEMCAS, they were not similar with respect to increase in SBP 
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percentiles. However, a set of important differences between both studies might 
explain these differences: Pobee and co-workers used a mean of three blood 
pressure measurements, whereas in GEMCAS it was only a single measurement, 
also the various ethnicities, the much younger study population (<45 years) and 
the noticeable lower sample size in the Ghanaian might all play an important role.  
In another study conducted by Lim et al. (2000) from a Malaysian sample of 
9,656 subjects aged 30 years and above, there was a clear increase of SBP 
percentiles with respect to age. In women they reported an increase of at least a 
20 mmHg of SBP from the youngest (30-34 years) to the oldest (>70 years) in all 
the percentiles (5th, 25
th, 50th, 75th, 95th). These increases of 20 mmHg they 
observed in men for the 50th, 75th and 95th percentiles, too (Lim et al. 2000). 
Although this study used two measurements for the assessment of blood 
pressure, their results are well in concordance with the results of GEMCAS 
women.  
The age related increase of DBP percentiles was comparable to all studies 
citied here, especially in studies with high sample sizes. Pobee et al. 1977 and Lim 
et al. 2000 reported an only small age related shift of DBP, the median DBP 
across youngest to oldest age groups differed by less than 5 mmHg (Pobee et al. 
1977, Lim et al. 2000 ). In GEMCAS the median DBP value was almost constant 
for men and differed by 10 mmHg between younger and older age groups in 
women.  
 
5.4 Sensitivity analyses  
Azizi et al. (2002) described the distribution of blood pressure in Iranian 
population from the Tehran Lipid and Glucose study. They analysed blood 
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pressure data from 7,825 participants aged between 20-69 years, not taking any 
antihypertensive medications. An age-related increase (age group 20-29 to 60-69 
years) in systolic blood pressure in both sexes can be abstracted from the tables 
by Azizi et al (Azizi et al. 2002). This increase ranges from 15 mmHg in the 5th 
percentile to 44 mmHg in the 95th percentile in women. This is well in line with the 
GEMCAS data of 15-35 mmHg (cf. figure 6a) taking into account the subgroup of 
participants without antihypertensive treatment and the age range of the study 
group of Azizi et al. (at most 69 years). In men, the respective data in the Azizi et 
al. study were 8-39 mmHg; in GEMCAS sample the age-related increase was 
lower, especially in the highest percentile (10-15 mmHg). 
Azizi et al. observed that the DBP percentiles (5th, 25th, 50th, and 75th) did 
not differ by more than 5 mmHg across the age groups in both the sexes (Azizi et 
al. 2002). The age related increases in DBP observed in the GEMCAS sub-sample 
of subjects with no antihypertensive medications intake, differed slightly with the 
increases in DBP percentiles observed by Azizi et al. In the GEMCAS sub-sample 
men showed a difference of at least 10 mmHg across ages in 5th, 25th, 75th, and 
95th percentiles, whereas women showed a difference of at least 10 mmHg in the 
50th, 75th, and 95th percentiles.  
 
5.5  Validation of the effects of age 
 In cross-sectional studies that investigated the effects of age upon blood 
pressure, although it is well established that age has an effect on blood pressure, 
the limitation of the study design does not allow to draw conclusions about 
causality that, the observed effects are due to age alone. The effects of age upon 
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blood pressure observed in cross-sectional studies might be due to a) Selective 
survivorship or b) Birth cohort effects.   
 Selective survivorship (shifting the blood pressure readings downwards) is 
a widely postulated concept within cross-sectional studies. To overcome these 
limitations of the cross-sectional study, the observed age-effect in GEMCAS (by 
calculating estimators for the age effect) was validated by applying on baseline 
blood pressure data in HNR to compute expected blood pressure readings in the 
HNR subjects. These expected blood pressure readings were then compared with 
the measured blood pressure readings in the 5 year follow up examination. To my 
knowledge there is no study that validated the effects of age observed in a cross-
sectional data set with an independent longitudinal study, and this work is the first 
to do so. In men the expected SBP was only 1.8 mmHg higher compared to the 
measured SBP. In women this difference was even lower with 0.9 mmHg, and 
despite the high sample size it was non-significant. The slight differences in the 
age related effects in both the GEMCAS and Heinz Nixdorf Recall study sample 
could be possibly due to the risk factor profiles of the subjects. GEMCAS being a 
patient based sample is expected to have subjects with higher risk factors and 
receive more pharmacotherapy, which could influence the progression of blood 
pressure with age. BMI and weight gain are considered to be some of the 
important risk factors for the progression of blood pressure (Vasan et al. 2001). 
GEMCAS subjects were more obese than the HNR subjects (cf. Table 4).  Also 
well known risk factors for increasing blood pressure like physical activity, smoking 
habits, diet with high salt intake and family history of hypertension, could be 
reasons for a difference in the blood pressure progression in both the study 
samples. 
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Thus from this analyses it could be shown that, although with slight 
differences, the age effect upon blood pressure observed in the cross-sectional 
study GEMCAS was reproducible in an independent , HNR longitudinal study for 
men and women aged from 45 to 75 years.  
 
5.6 Strengths and Limitations of the work 
The strengths of this work include the nationwide approach, the large 
sample size and the extensive quality assurance concept of the GEMCAS study. 
The large study size allows a comprehensive description of the full range of the 
blood pressure distribution and provides sufficient precision even when stratifying 
the sample into small age groups, sex, or presence or absence of risk factors. A 
notable advantage of the GEMCAS study is the broad age range, which includes 
very old individuals even over the age of ninety. The reliability of the GEMCAS 
data is also a strength for this work. Although the GEMCAS study is a patient 
based sample it has been successfully used as a population control for other 
clinical studies (Kahl et al. 2010, Kahl et al. 2011). A further strength of this work is 
the comparison and validation of the GEMCAS finding with data of the well-known 
prospective Heinz Nixdorf Recall Study. As to my knowledge, there is no study 
that validated the effects of age observed in a cross-sectional study in an 
independent longitudinal data and this work is the first of its kind. Since special 
cardiology practices were excluded from the study, there is a possibility that very 
high blood pressure readings may have been underreported. However, the blood 
pressure readings in GEMCAS are comparable to those of the German National 
Health Interview and Examination Survey from 1998 (Thamm 1999). The study 
characteristics of this primary health care sample are comparable to other German 
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population-based samples and to the German federal statistical data with regard to 
anthropometric measures, smoking status, marital status, schooling and 
unemployment rate (i.e. GEMCAS: 10.2%, Germany October 2005: 10.4%). This 
high conformance might be explained by the fact that 92% of adults in Germany 
consult a general practitioner at least once a year (Kohler et al. 2004). 
Several aspects must be considered with regard to the blood pressure 
measurements. (1) Blood pressure measurements were conducted with 
automated and manual blood pressure devices, whichever was available at the 
participating physician‟s practice. As has been shown in other studies (Coe et al. 
2002, Stang et al. 2006) and replicated in GEMCAS study, automated devices 
systematically measure higher blood pressure values than manual devices. In 
GEMCAS, the mean systolic and diastolic blood pressures differed between 
manual and automated devices by +5 mmHg and +2 mmHg in men (and +3 
mmHg and +1 mmHg respectively in women). By way of comparison, in the study 
by Stang et al. (2006) the difference was reported to be 7.0 mmHg in men and 1.1 
mmHg in women for the systolic blood pressure, and 3.4 mmHg and 1.9 mmHg 
respectively for the diastolic blood pressure. However, over 70% of the sample 
had been measured with manual devices, and no evidence was found in GEMCAS 
that manual and automated devices were systematically distributed between the 
participating practices (i.e. automated devices in practices with a higher proportion 
of participants with high blood pressure readings). (2) GEMCAS results are based 
on one blood pressure measurement. The recommended double measurements 
with at least two minutes of recovery between measurements could not be 
accomplished in this real-life setting. Thus GEMCAS blood pressure readings are 
likely to be overestimated. However, the pattern of the overall distribution of both 
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systolic and diastolic blood pressure should not have been fundamentally 
influenced by this procedure. Furthermore, previous studies documented that 
accurate group means could be obtained with single readings. This is particularly 
true when the single blood pressure measurement is taken under appropriate 
conditions (Wolf-Maier et al. 2003). (3) As this was a cross-sectional study, the 
observed age-related courses of the blood pressure readings are influenced by 
possible selective survivorship (shifting the blood pressure readings downwards). 
Although selective survivorship is a widely postulated concept within cross-
sectional studies, it has been challenged particularly in relation to the diastolic 
blood pressure decline in older age by Franklin and co-workers (1997) who 
reported a late decline in diastolic blood pressure even after removing the 
deceased participants and subjects with non-fatal myocardial infarction or 
congestive heart failure from the study. (4) Birth cohort effects may have 
influenced the course of the blood pressure readings as well. The wide age-range 
of GEMCAS sample encompasses a number of birth cohorts (1906 – 1987) with 
different social and environmental conditions and lifestyles, resulting in different 
blood pressure readings. Therefore the observed age course in GEMCAS sample 
might be due to intergenerational effects.  However, i tried to observe for any 
possible birth cohort or healthy survivor effect by applying the age-effect estimated 
in GEMCAS in an independent longitudinal and population-based cohort HNR and 
were able to reproduce the age effects observed in GEMCAS in the independent 
longitudinal population based cohort.  
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5.7 Conclusions  
This study showed an age-related increase in the systolic blood pressure 
readings in all percentiles in both men and women, independent of the intake of 
antihypertensive medication, and/or presence of CVD or CVD risk factors. These 
data thus suggest that an age-related increase in the systolic blood pressure is 
independent of known associated risk factors for elevated blood pressure. This is 
the first study to provide detailed information on the population distribution of blood 
pressure readings relating to both sexes, very old individuals and CVD risk factors. 
One benefit of this study is that it may serve as a resource for planning future 
biomedical and epidemiological studies in which blood pressure plays a key role. 
The detailed descriptive statistics and especially the dispersion measures may 
help during sample size calculation and power analysis. Furthermore, these data 
are useful for public health issues in planning the extent of necessary prevention 
strategies tailored to affected age groups and both sexes to control progression 
into hypertension among people with normal blood pressure.  
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6. Summary 
Many epidemiological studies have addressed various aspects of blood 
pressure, ranging from descriptions of normal blood pressure distributions in 
different populations to the influence of age and other factors on blood pressure. 
However studies consider blood pressure in terms of hypertension, assessing 
prevalence, treatment and control of hypertension in diverse populations. Very few 
studies are available dealing with the distribution of blood pressure values in 
population as percentiles, none of which is from Europe and none of which 
addresses a wide age range, sex and coexisting cardiovascular risk factors.  
Therefore, main aim of this thesis was to examine in detail the distribution 
of blood pressure of a large cross sectional study sample of 35,869 women and 
men aged 18-99 years. The second aim was to validate the observed age-effects 
in the cross-sectional German Metabolic and Cardiovascular Risk Study, in the 
independent, longitudinal and population-based Heinz Nixdorf Recall study, using 
baseline and 5 year follow up data of 4,157 men and women, aged 45-75 years.  
This study showed an age-related increase of the systolic blood pressure in 
all percentiles in both men and women, independent of the intake of 
antihypertensive medication, and/or presence of Cardiovascular Disease (CVD) or 
CVD risk factors. This is the first study to provide detailed information on the 
population distribution of blood pressure readings relating to both sexes, very old 
individuals and CVD risk factors. Furthermore, the age related increase observed 
in the systolic blood pressure in the cross sectional study could be confirmed for 
men and women, aged 45-75 years in the independent, longitudinal Heinz Nixdorf 
Recall study.  
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Table 1: Comparison of characteristics of GEMCAS subjects according to blood pressure in men (crude and age-
standardized) 
 
 Normal Blood Pressure 
 n=1,555 
Prehypertension 
n=6,042 
Stage I Hypertension 
n=4,397 
Stage II Hypertension 
n=1,880 
 Crude Standardized Crude Standardized Crude Standardized Crude Standardized 
Blood Pressure (BP)         
 SBP (mmHg) mean ± SE 107.7± 0.2 107.7± 0.3 125.1 ± 0.09 124.9 ± 0.2 141.6 ± 0.1 140.7 ± 0.3 163.8 ± 0.4 160.6 ± 0.5 
 DBP (mmHg) mean ± SE 67.9 ± 0.2 67.9 ± 0.3 78.0 ± 0.07 77.9 ± 0.2 85.1± 0.1 85.7 ± 0.3 94.9 ± 0.3 96.9 ± 0.4 
Weight (kg) mean ±SE 79.5± 0.3 79.5± 0.4 84.9± 0.2 84.5± 0.3 88.4± 0.2 89± 0.4 90.5± 0.4 92.6± 0.5 
BMI         
 ≤ 25 kg/m
2
 53.5 52.4 33.3 36.6 21.8 25.9 16.4 18.3 
 25 - < 30 kg/m
2
 34.5 35.1 46.5 44.7 48.0 45.1 46.8 43.4 
 ≥ 30 kg/m
2
 12.0 12.5 20.2 18.7 30.1 29.0 36.8 38.3 
WC (cm) mean ± SD 91.7± 0.3 92.2±0.4 97.0± 0.2 95.8±0.3 101.6± 0.2 99.6±0.3 104.0± 0.3 103.0± 0.5 
Lipid Profile         
 TC (mmol/l) mean ± SE 5.0 ± 0.03 5.0 ± 0.02 5.2 ± 0.01 5.1 ± 0.01 5.4 ± 0.02 5.3 ± 0.02 5.4 ± 0.02 5.4 ± 0.02 
 HDL (mmol/l) mean ± SE 1.4 ± 0.01 1.4 ± 0.01 1.4 ± 0.00 1.4 ± 0.01 1.4 ± 0.01 1.4 ± 0.01 1.4 ± 0.01 1.4 ± 0.01 
 LDL (mmol/l) mean ± SE 3.1 ± 0.02 3.1 ± 0.02 3.3 ± 0.01 3.1 ± 0.01 3.4 ± 0.01 3.3 ± 0.01 3.4 ± 0.02 3.4 ± 0.02 
 TG (mmol/l) median (IQR) 
 Geometric mean ± SE 
1.3 (0.9; 2.0) 
1.4(0.01) 
- 
1.4(0.01) 
1.6 (1.1; 2.3) 
1.6(0.01) 
- 
1.6(0.01) 
1.7 (1.2; 2.6) 
1.8(0.01) 
- 
1.8(0.01) 
1.8 (1.2; 2.8) 
1.9(0.01) 
- 
1.9(0.01) 
Blood glucose (mmol/l) mean ± SE 5.2 ± 0.04 5.2 ± 0.03 5.5 ± 0.02 5.4 ± 0.02 6.0 ± 0.03 5.7 ± 0.03 6.3 ± 0.06 5.7 ± 0.04 
Pharmacotherapy (%)         
 Anti-diabetic 7.0 7.5 9.5 8.2 14.9 10.6 17.8 12.6 
 Anti-hypertensive 24.2 26.6 34.1 30.1 50.0 37.7 62.1 45.2 
 Lipid lowering 14.2 15.3 17.0 14.7 19.4 13.7 22.0 14.2 
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Table 1 (cont.): Comparison of characteristics of GEMCAS subjects according to blood pressure in men (crude and age-
standardized) 
 Normal Blood Pressure 
 n=1,555 
Prehypertension 
n=6,042 
Stage I Hypertension 
n=4,397 
Stage II Hypertension 
n=1,880 
 Crude Standardized Crude Standardized Crude Standardized Crude Standardized 
Smoking status (%)         
 Current Smoker 37.3 35.8 28.9 31.3 24.4 30.6 21.8 29.5 
 Past Smoker 29.5 30.9 37.5 34.3 43.8 36.1 46.4 38.0 
 Never Smoker 33.1 33.3 33.7 34.4 31.8 33.3 31.8 32.5 
Comorbidities (%)         
 Cardiovascular disease 17.9 20.0 18.9 16.5 24.4 16.7 27.1 16.9 
 Diabetes 9.3 9.9 13.3 11.5 20.6 14.8 24.1 16.6 
Legend: Normal blood pressure (SBP< 120 and DBP< 80 mmHg ); Prehypertension (SBP 120-139 or DBP 80-89 mmHg); Stage I 
Hypertension (SBP 140-159 or DBP 90-99 mmHg) ; Stage II Hypertension (SBP ≥160 or DBP≥ 100 mmHg);  SBP, systolic blood pressure; 
DBP, diastolic blood pressure; BP, blood pressure; SD, standard deviation; SE, standard error; BMI, body mass index; WC, waist 
circumference; TC, total cholesterol; TG, triglycerides; IQR, interquartile range 
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Table 2: Comparison of characteristics of GEMCAS subjects according to blood pressure in women (crude and age-
standardized) 
 
 Normal Blood Pressure 
 n=4,781 
Prehypertension 
n=9.417 
Stage I Hypertension 
n=5,352 
Stage II Hypertension 
n=2,262 
 Crude Standardized Crude Standardized Crude Standardized Crude Standardized 
Blood Pressure (BP)         
 SBP (mmHg) mean ± SE 106.4 ± 0.1 107.0 ± 0.2 123.7 ± 0.1 123.9 ± 0.2 141.3 ± 0.1 139.8 ± 0.3 164.8 ± 0.3 161.6 ± 0.5 
 DBP (mmHg) mean ± SE 67.6 ± 0.1 67.5 ± 0.2 77.9 ± 0.1 77.6 ± 0.2 85.2 ± 0.1 85.8 ± 0.2 94.8 ± 0.3 96.6 ± 0.4 
Weight (kg) mean ±SE 64.7± 0.2 66.1± 0.3 71.5± 0.2 71.1± 0.3 76.6± 0.2 76.7± 0.4 78.3± 0.4 81.0± 0.6 
BMI         
 ≤ 25 kg/m
2
 72.2 64.0 48.0 48.7 29.2 33.7 24.1 25.7 
 25 - < 30 kg/m
2
 20.6 26.7 31.4 31.2 35.8 33.0 35.3 31.8 
 ≥ 30 kg/m
2
 7.1 8.9 20.6 20.1 35.1 33.3 40.7 42.5 
WC (cm) mean ± SD 78.2± 0.2 80.9± 0.3 85.9± 0.1 85.8± 0.3 92.7± 0.2 91.2± 0.3 94.8± 0.3 94.2± 0.5 
Lipid Profile         
 TC (mmol/l) mean ± SE 5.0 ± 0.01  5.2 ± 0.01 5.4 ± 0.01 5.4 ± 0.01 5.6 ± 0.01 5.4 ± 0.01 5.8 ± 0.02 5.5 ± 0.01 
 HDL (mmol/l) mean ± SE 1.8 ± 0.01 1.8 ± 0.01 1.8 ± 0.01 1.8 ± 0.01 1.7 ± 0.01 1.7 ± 0.01 1.7 ± 0.01 1.7 ± 0.01 
 LDL (mmol/l) mean ± SE 3.0 ± 0.01 3.1 ± 0.01 3.3 ± 0.01 3.3 ± 0.01 3.5 ± 0.01 3.4 ± 0.01 3.6 ±0.02 3.4 ± 0.02 
 TG (mmol/l) median (IQR) 
  
Geometric mean ± SE 
 
1.0 (0.8; 1.5) 
 
1.1±0.01 
- 
 
1.2± 0.01 
1.3 (0.9; 1.8) 
 
1.3± 0.01 
- 
 
1.3± 0.01 
1.5 (1.1;2.2) 
 
1.5± 0.01 
- 
 
1.5± 0.01 
1.6 (1.1;2.2) 
 
1.6± 0.01 
- 
 
1.6± 0.01 
Blood glucose (mmol/l) mean ± SE 4.8 ± 0.01 5.0 ± 0.02 5.1 ± 0.01 5.2 ± 0.02 5.6 ± 0.03 5.2 ± 0.02 5.9 ± 0.05 5.6 ± 0.03 
Pharmacotherapy (%)         
 Anti-diabetic 2.1 4.6 5.4 5.9 11.2 8.4 14.3 9.3 
 Anti-hypertensive 11.1 24.9 28.7 30.9 51.9 41.5 64.6 48.2 
 Lipid lowering 4.0 9.5 9.1 10.0 16.2 11.9 16.6 10.5 
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Table 2 (cont.): Comparison of characteristics of GEMCAS subjects according to blood pressure in women (crude and 
age-standardized) 
 Normal Blood Pressure 
 n=1,555 
Prehypertension 
n=6,042 
Stage I Hypertension 
n=4,397 
Stage II Hypertension 
n=1,880 
 Crude Standardized Crude Standardized Crude Standardized Crude Standardized 
Smoking status (%)         
 Current Smoker 32.0 25.3 24.5 23.4 17.8 21.9 14.2 20.3 
 Past Smoker 21.2 21.1 23.0 22.0 22.5 21.5 21.3 20.1 
 Never Smoker 46.8 53.5 52.5 54.5 59.7 56.7 64.6 59.6 
Comorbidities (%)         
 Cardiovascular disease 5.0 14.8 10.0 12.4 17.2 13.6 21.4 14.9 
 Diabetes 3.2 7.8 7.8 8.7 16.1 12.3 19.9 14.1 
Legend: Normal blood pressure (SBP< 120 and DBP< 80 mmHg ); Prehypertension (SBP 120-139 or DBP 80-89 mmHg); Stage I 
Hypertension (SBP 140-159 or DBP 90-99 mmHg) ; Stage II Hypertension (SBP ≥160 or DBP≥ 100 mmHg);  SBP, systolic blood pressure; 
DBP, diastolic blood pressure; BP, blood pressure; SD, standard deviation; SE, standard error; BMI, body mass index; WC, waist 
circumference; TC, total cholesterol; TG, triglycerides; IQR, interquartile range 
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